BUSINESS

• PMP Returns Slam Drug Makers' Leading Products, Prazaxa Cut 45%: Jiho Poll
  March 13, 2026

• Lilly to Invest Additional 20 Billion Yen in Japan's Seishin Plant
  March 13, 2026

• Fujifilm Invests in Austria’s Valanx Biotech to Boost ADC Technology
  March 13, 2026

• Merck, CDMO Cyto-Facto Join Hands on Cell and Gene Therapy
  March 13, 2026

• Anti-PD-1 Agonist Antibody Enters PI in Australia for Autoimmune Diseases: Meiji
  March 13, 2026

• Half of Drug Makers Reluctantly Support G1 Rule Overhaul: Jiho Survey
  March 12, 2026

• FDA Resumes Review of Capricor/Nippon Shinyaku’s DMD Cell Therapy
  March 12, 2026

• Hisamitsu Starts Promotion of Yaz AGs under Bayer Alliance
  March 11, 2026

• Seagen ADC Patent Dispute Ends with Daiichi Sankyo Victory
  March 11, 2026

• Seikagaku Re-Files Herniated Disk Drug with US FDA
  March 11, 2026

• Lotte to Step Up CVC Investments to Drive CDMO Synergies
  March 10, 2026

• Ipsen to Withdraw Tazverik Overseas over Secondary Cancer Risk
  March 10, 2026

• Minimum Price Hike, Spillover Abolition Win Industry Support in FY2026 Reform: Jiho Poll
  March 10, 2026

• Xospata Misses OS Endpoint in PIII Trial in Untreated FLT3-Mutated AML
  March 10, 2026

• Enhertu Now under US Review for Post-Neoadjuvant HER2 Breast Cancer
  March 10, 2026

• Lesoeru 72 OTC Emergency Contraceptive Hits Market at 6,300 Yen
  March 10, 2026

• Pfizer, ASKA to Co-Promote RSV Vaccine Abrysvo in Japan
  March 9, 2026

• Sumitomo to Launch Post-Marketing Study for iPSC Therapy by Year-End
  March 9, 2026

• Drug Pricing Reform Draws Sharp Industry Backlash in Jiho Poll
  March 9, 2026

• Nitrosamine Detected in Nichi-Iko’s Tryptanol, No Need to Halt Prescriptions
  March 9, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »